CANCER RESEARCH CAREER ENHANCEMENT The UNC Lineberger Comprehensive Cancer Center (LCCC) has a long history of successful training programs and other mentoring, career enhancement and educational activities, across the continuum of career stages. These include: pre-college and undergraduate students, pre- and post-doctoral fellows, junior faculty and rising senior faculty, health care and biomedical research professionals and LCCC research staff and administrators. Since its inception, the Cancer Research Career Enhancement (CRCE) Core has focused on integrating these current UNC LCCC activities and strengths in cancer research career enhancement and addressing gaps in the training portfolio. Led by faculty and staff with extensive training, mentorship, research and leadership experience, the Core is well equipped to meet the evolving needs of a large, diverse and dynamic Cancer Center. The specific activities offered by the CRCE include: 1) Identifying, integrating, and organizing resources for cancer-related education, training, and career development; 2) Promoting cancer research education and training for our professional degree candidates and post-graduate trainees; 3) Providing training, development, and continuing education opportunities for faculty of all stages; and 4) Stimulating excitement and interest in cancer research through educational outreach to the broader non-cancer community. The CRCE promotes these initiatives through efforts such as: the LCCC-NC School of Math and Science pre-college cancer research program; LCCC undergraduate cancer research training including an NCI-funded partnership with a nearby Historically Black College or University (North Carolina Central University); engagement with the North Carolina Community College system for cancer education/training; multiple NCI T32 training programs for pre- and post-doctoral fellows; the Lineberger-Lauterborn Nursing Oncology Fellowship program; the Junior Faculty Career Development Group; and multiple meetings and events that add value to the LCCC by facilitating cross-disciplinary collaboration and innovation. These training opportunities have yielded impressive results such as 85% of previous trainees from our LCCC- North Carolina Central University PARTNERs program attending graduate or medical school. LCCC total direct costs funding from 67 training awards, including 11 NCI T32 awards, totals $10.7M. Over the next five years, the CRCE will improve or systematize ongoing activities by: broadening our partnership efforts with the LCCC COE; developing methods for collecting and analyzing outcomes from CRCE programs including longitudinal tracking of all trainees; expanding the NC Community College program; and designing new programs to serve a broader base of CRCE constituents. CRCE also strives to increase the diversity of students, trainees, and faculty at UNC and in the larger cancer research community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089810
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Shen, Hui; Shih, Juliann; Hollern, Daniel P et al. (2018) Integrated Molecular Characterization of Testicular Germ Cell Tumors. Cell Rep 23:3392-3406
Shao, Wenwei; Chen, Xiaojing; Samulski, Richard J et al. (2018) Inhibition of antigen presentation during AAV gene therapy using virus peptides. Hum Mol Genet 27:601-613
Gao, Yanzhe; Kardos, Jordan; Yang, Yang et al. (2018) The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells. Sci Rep 8:15304
Schaefer, Kristina N; Bonello, Teresa T; Zhang, Shiping et al. (2018) Supramolecular assembly of the beta-catenin destruction complex and the effect of Wnt signaling on its localization, molecular size, and activity in vivo. PLoS Genet 14:e1007339
Zuze, Takondwa; Painschab, Matthew S; Seguin, Ryan et al. (2018) Plasmablastic lymphoma in Malawi. Infect Agent Cancer 13:22
Wang, Jeremy R; Holt, James; McMillan, Leonard et al. (2018) FMLRC: Hybrid long read error correction using an FM-index. BMC Bioinformatics 19:50
Lee, Janie M; Abraham, Linn; Lam, Diana L et al. (2018) Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. J Clin Oncol 36:2070-2077
Thomas, Nancy E; Edmiston, Sharon N; Orlow, Irene et al. (2018) Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes. J Invest Dermatol 138:2398-2404
Cousins, Emily M; Goldfarb, Dennis; Yan, Feng et al. (2018) Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3? and Activates WNT Signaling. Mol Cancer Res 16:333-344
Armstrong, Robin L; Penke, Taylor J R; Strahl, Brian D et al. (2018) Chromatin conformation and transcriptional activity are permissive regulators of DNA replication initiation in Drosophila. Genome Res 28:1688-1700

Showing the most recent 10 out of 1525 publications